Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

NCT01579929 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: LDE225, Etoposide and Cisplatin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]